In PCa, overexpression of bcl-2 is related to high grades and advanced stages, and is considered a prognostic marker for poor outcome and resistance to ADT (reviewed by Quinn et al. [29] (Figure 3(b)). This evidence concerns the gene BCL2 and posterior cortical atrophy.